
Richard Harris
Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.
Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.
Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.
Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.
Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington Star in DC.
Harris is co-founder of the Washington, DC, Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.
Harris' book Rigor Mortis was published in 2017. The book covers the biomedicine "reproducibility crisis" — many studies can't be reproduced in other labs, often due to lack of rigor, hence the book's title. Rigor Mortis was a finalist for the 2018 National Academy of Sciences/Keck Communication Award.
A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.
-
More than 600 people will take part in study to test a promising treatment for Huntington's disease, a fatal inherited condition. The experimental drug interferes with defective genetic machinery.
-
Behavior and environment are big factors in a surge in obesity. Scientists are busy trying to identify the many genes that play a role in weight gain to develop a predictive obesity test.
-
Ethical concerns aside, the genetic ingredients for human traits are so complex that editing a few embryonic genes is unlikely to have much effect — or achieve the fantasy of enhancing humans.
-
Will AI in health care create a two-tiered system in which poorer people will be seen by a computer instead of a doctor? That's one concern about the burgeoning technology.
-
The search giant's push into artificial intelligence as a tool for health improvement is a natural evolution for a company that has developed algorithms that reach deep into our lives through the Web.
-
The latest advance is not only encouraging news for patients with severe combined immunodeficiency. It's a test case for all those scientists working to develop better gene therapy techniques.
-
Software that can replace doctors for certain tasks has a big responsibility. The Food and Drug Administration is now figuring out how to determine when computer algorithms are safe and effective.
-
Artificial intelligence is now being brought to bear on mammograms and could improve the accuracy of diagnoses. But previous computerized technology to do that didn't live up to the hype.
-
Drugmakers add inactive ingredients to stabilize medications and sometimes to help the body absorb the active ingredients. But the inactive constituents can cause side effects in rare cases.
-
British doctors report the apparent eradication of HIV from a patient who was undergoing treatment for cancer. It's only the second time this has been accomplished, despite many attempts.